The effects of Piacidin in treatment of diabetes

Phase 3

Recruiting

• Conditions: type 2 diabetes mellitus.; E11; Type 2 dia

• Registration Number: IRCT20110614006804N3
• Lead Sponsor: Bagheiat-allah University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 6 March 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 66

Inclusion Criteria

1- Blood triglyceride level should be between 150 and 500 mg/dL. 2- HbA1c level should be less than 8.5%. 3- The age of patients should be between 30 and 65 years. 4- Patients should not make any changes in their blood sugar lowering drug regimen or their physical activity.5- Patients should not have systemic diseases or malignancy or chronic kidney or liver diseases.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quantitative measurement of serum nitric Oxide, glutathione and malondialdehyde levels, blood sugar and lipid levels. Timepoint: before drug administration (day 0) and 3 month after drug administration (day 90). Method of measurement: Oxidative stress and nitric oxide serum levels will be measured using specific biochemical kits, blood sugar and lipids variables will be assessed based on individual laboratory sample results.

Secondary Outcome Measures

Name	Time	Method
one applicable. Timepoint: none applicable. Method of measurement: none applicable.